RBM10 and breast cancer: Paradoxically, expression of RBM10 (like its paralogue, the tumor suppressor RBM5) is elevated in some cancers, such as multiple endocrine neoplasia type 1 [14], breast cancers [15], liver and colon cancers [16] and some metastatic melanomas [17].